- ICH GCP
- US Clinical Trials Registry
- Researchers
- Brazil
- Leukemia, Lymphocytic, Chronic, B-Cell
Medical specialists from Brazil tagged as investigators in clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell
Total 18 results
-
Carlos Eduardo MiguelSeen in:
- Sao Paulo, Sao Jose Rio Preto, Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto
- São José do Rio Preto, Centro Integrado de Pesquisa Clinica
Trials:- NCT05254743 (Principal Investigator)
-
Danielle Leão Cordeiro de FariasSeen in:
- Sao Paulo, Hospital Beneficencia Portuguesa de Sao Paulo
- São Paulo, Sao Paulo, BP - A Beneficencia Portuguesa de São Paulo
Trials:- NCT05254743 (Principal Investigator)
-
Debora Rodrigues BonitoSeen in:
- São Paulo, Santo André, CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia
Trials:- NCT05254743 (Principal Investigator)
-
Diego Villa CléSeen in:
- São Paulo, Ribeirão Preto, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) - HCFMRP
- São Paulo, Ribeirão Preto, Hospital de Clínicas de Ribeirão Preto
Trials:- NCT05254743 (Principal Investigator)
-
Éderson Roberto de MattosSeen in:
- São Paulo, Jaú, Fundacao Doutor Amaral Carvalho
Trials:- NCT05023980 (Principal Investigator)
Conditions: -
Fernando Vieira Pericole de SouzaSeen in:
- Sao Paulo, Campinas, Centro de Hematologia e Hemoterapia - Hemocentro de Campinas - UNICAMP
- São Paulo, Campinas, Hemocentro Unicamp
Trials:- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Gabriela Almeida GarciaSeen in:
- Cascavel, Hospital Uopeccan - Centro de Pesquisa Clinica
Trials:- NCT05254743 (Principal Investigator)
-
Joao Samuel de Holanda FariasSeen in:
- Paraná, Curitiba, Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer
Trials:- NCT05254743 (Principal Investigator)
-
Lucila Kerbauy, MD, PhHSeen in:
- São Paulo, Hospital Israelita Albert Einstein
Trials:- NCT05705570 (Sub-Investigator)
-
Marcelo CapraSeen in:
- Rio Grande Do Sul, Porto Alegre, Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa - Hospital Mae de Deus
- Rio Grande Do Sul, Porto Alegre, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Michel Michels de OliveiraSeen in:
- Paraná, Curitiba, CIONC-Centro Integrado de Oncologia de Curitiba
- Paraná, Curitiba, Centro Integrado de Oncologia de Curitiba
Trials:- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Moema Nene SantosSeen in:
- Rio Grande Do Sul, Passo Fundo, Instituto do Câncer - Hospital São Vicente de Paulo
Trials:- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Nelson Siqueira de CastroSeen in:
- São Paulo, Barretos, Fundação Pio XII - Hospital de Câncer de Barretos
Trials:- NCT05254743 (Principal Investigator)
-
Patricia de Paulo GiaconSeen in:
- SP, Sao Paulo, Hospital Santa Marcelina
- Sao Paulo, Hospital Santa Marcelina
Trials:- NCT05254743 (Principal Investigator)
-
Rafael Dezen GaiollaSeen in:
- Sao Paulo, Botucatu, UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu
- São Paulo, Botucatu, Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
Trials:- NCT05254743 (Principal Investigator)
-
Raphael Costa Bandeira de MeloSeen in:
- São Paulo, Hospital Das Clinicas Da Faculdade De Medicina Da USP
- São Paulo, Hospital da Clinicas da Faculdade de Medicina da USP
Trials:- NCT05254743 (Principal Investigator)
-
Sergio SilvaSeen in:
- Minas Gera, Belo Horizonte, Centro de Pesquisas Clínicas do Hospital das Clínicas da UFMG - Ebserh
Trials:- NCT05254743 (Principal Investigator)
-
Tito Emilio Vanelli CostaSeen in:
- Rio Grande Do Sul, Porto Alegre, Irmandade Da Santa Casa de Misericordia de Porto Alegre
Trials:- NCT05023980 (Principal Investigator)
Conditions:
Clinical Trials on Leukemia, Lymphocytic, Chronic, B-Cell
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...United States
-
Fred Hutchinson Cancer Research Center/University...WithdrawnB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
-
French Innovative Leukemia OrganisationTerminatedB-cell Chronic Lymphocytic Leukemia (B-CLL)France
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
National Cancer Institute (NCI)TerminatedB-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Genzyme, a Sanofi CompanyCompletedB Cell Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
CelgeneCompletedB-cell Chronic Lymphocytic LeukemiaUnited States, Spain, United Kingdom, Canada, Belgium, Czechia, Hungary, Italy, Poland, Israel, Germany, Ireland, France, New Zealand, Denmark, Australia, Netherlands, Romania, Russian Federation, Sweden, Austria, South Africa, Colo... and more
-
French Innovative Leukemia OrganisationRoche Pharma AGCompletedB-cell Chronic Lymphocytic Leukemia CLLFrance
-
OnxeoCompletedB-cell Chronic Lymphocytic LeukemiaUnited Kingdom